Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Philip Castle

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Living Beings

Chemicals & Drugs

Viral DNA

Procedures

Geographic Areas

Costa Rica

Anatomy

Cervix Uteri

Concepts & Ideas

Physiology

Genotype

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Katki Hormuzd A; Wacholder Sholom; Solomon Diane; Castle Philip E; Schiffman Mark
Risk estimation for the next generation of prevention programmes for cervical cancer.
Castle Philip E; Sadorra Mark; Lau Tiffany; Aldrich Carrie; Garcia Francisco A R; Kornegay Janet
Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping.
Castle Philip E; Rodríguez Ana C; Burk Robert D; Herrero Rolando; Hildesheim Allan; Solomon Diane; Sherman Mark E; Jeronimo Jose; Alfaro Mario; Morales Jorge; Guillén Diego; Hutchinson Martha L; Wacholder Sholom; Schiffman Mark
Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Philip Castle (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Katki Hormuzd A; Wacholder Sholom; Solomon Diane; Castle Philip E; Schiffman Mark
Risk estimation for the next generation of prevention programmes for cervical cancer.
The lancet oncology 2009;10(11):1022-3.
2009: Castle Philip E; Sadorra Mark; Lau Tiffany; Aldrich Carrie; Garcia Francisco A R; Kornegay Janet
Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping.
Journal of clinical microbiology 2009;47(10):3344-7.
2009: Castle Philip E; Rodríguez Ana C; Burk Robert D; Herrero Rolando; Hildesheim Allan; Solomon Diane; Sherman Mark E; Jeronimo Jose; Alfaro Mario; Morales Jorge; Guillén Diego; Hutchinson Martha L; Wacholder Sholom; Schiffman Mark
Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer.
International journal of cancer. Journal international du cancer 2009;125(7):1649-56.
2009: Cox John Thomas; Moriarty Ann T; Castle Philip E
Commentary on statement on human papillomavirus test utilization.
Archives of pathology & laboratory medicine 2009;133(8):1192-4.
2009: Castle Philip E; Fetterman Barbara; Akhtar Israh; Husain Mujtaba; Gold Michael A; Guido Richard; Glass Andrew G; Kinney Walter
Age-appropriate use of human papillomavirus vaccines in the U.S.
Gynecologic oncology 2009;114(2):365-9.
2009: Cox John Thomas; Moriarty Ann T; Castle Philip E
Commentary on: Statement on HPV DNA test utilization.
Journal of lower genital tract disease 2009;13(3):131-4.
2009: Castle Philip E; Kreimer Aimée R; Wacholder Sholom; Wheeler Cosette M; Koutsky Laura A; Rydzak Greg; Buckman Dennis W; Graubard Barry; Schiffman Mark
Influence of loop electrosurgical excision procedure on subsequent acquisition of new human papillomavirus infections.
The Journal of infectious diseases 2009;199(11):1612-20.
2009: Wentzensen Nicolas; Gravitt Patti E; Solomon Diane; Wheeler Cosette M; Castle Philip E
A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(5):1341-9.
2009: Safaeian Mahboobeh; Schiffman Mark; Gage Julia; Solomon Diane; Wheeler Cosette M; Castle Philip E
Detection of precancerous cervical lesions is differential by human papillomavirus type.
Cancer research 2009;69(8):3262-6.
2009: Castle Philip E; Fetterman Barbara; Poitras Nancy; Lorey Thomas; Shaber Ruth; Kinney Walter
Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting.
Obstetrics and gynecology 2009;113(3):595-600.
2009: Castle Philip E; Rodríguez Ana Cecilia; Burk Robert D; Herrero Rolando; Wacholder Sholom; Alfaro Mario; Morales Jorge; Guillen Diego; Sherman Mark E; Solomon Diane; Schiffman Mark;
Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study.
BMJ (Clinical research ed.) 2009;339():b2569.
2009: Castle Philip E
The evolving definition of carcinogenic human papillomavirus.
Infectious agents and cancer 2009;4():7.
2008: Castle Philip E; Porras Carolina; Quint Wim G; Rodriguez Ana Cecilia; Schiffman Mark; Gravitt Patti E; González Paula; Katki Hormuzd A; Silva Sandra; Freer Enrique; Van Doorn Leen-Jan; Jiménez Silvia; Herrero Rolando; Hildesheim Allan;
Comparison of two PCR-based human papillomavirus genotyping methods.
Journal of clinical microbiology 2008;46(10):3437-45.
2008: Castle Philip E; Cox J Thomas; Schiffman Mark; Wheeler Cosette M; Solomon Diane
Factors influencing histologic confirmation of high-grade squamous intraepithelial lesion cytology.
Obstetrics and gynecology 2008;112(3):637-45.
2008: Castle Philip E; Solomon Diane; Wheeler Cosette M; Gravitt Patti E; Wacholder Sholom; Schiffman Mark
Human papillomavirus genotype specificity of hybrid capture 2.
Journal of clinical microbiology 2008;46(8):2595-604.
2008: LaMere Brandon J; Howell Renee; Fetterman Barbara; Shieh Jen; Castle Philip E;
Impact of 6-month frozen storage of cervical specimens in alkaline buffer conditions on human papillomavirus genotyping.
Journal of virological methods 2008;151(2):298-300.
2008: Castle Philip E
Invited commentary: is monitoring of human papillomavirus infection for viral persistence ready for use in cervical cancer screening?
American journal of epidemiology 2008;168(2):138-44; discussion 145-8.
2008: Gravitt Patti E; Schiffman Mark; Solomon Diane; Wheeler Cosette M; Castle Philip E
A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(5):1248-54.
2008: Castle Philip E; Cox J Thomas; Jeronimo Jose; Solomon Diane; Wheeler Cosette M; Gravitt Patti E; Schiffman Mark
An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS).
Obstetrics and gynecology 2008;111(4):847-56.
2008: Rodríguez Ana Cecilia; Schiffman Mark; Herrero Rolando; Wacholder Sholom; Hildesheim Allan; Castle Philip E; Solomon Diane; Burk Robert;
Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.
Journal of the National Cancer Institute 2008;100(7):513-7.
2008: Castle Philip E
The potential utility of HPV genotyping in screening and clinical management.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(1):83-95.
2008: Castle Philip E; Sideri Mario; Jeronimo Jose; Solomon Diane; Schiffman Mark
Risk assessment to guide the prevention of cervical cancer.
Journal of lower genital tract disease 2008;12(1):1-7.
2008: Castle Philip E; Gravitt Patti E; Solomon Diane; Wheeler Cosette M; Schiffman Mark
Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study.
Journal of clinical microbiology 2008;46(1):109-17.
2008: Mariategui J; Santos C; Taxa L; Jeronimo J; Castle P E
Comparison of depth of necrosis achieved by CO2- and N2O-cryotherapy.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2008;100(1):24-6.
2007: Safaeian Mahboobeh; Solomon Diane; Castle Philip E
Cervical cancer prevention--cervical screening: science in evolution.
Obstetrics and gynecology clinics of North America 2007;34(4):739-60, ix.
2007: LaMere Brandon J; Kornegay Janet; Fetterman Barbara; Sadorra Mark; Shieh Jen; Castle Philip E;
Human papillomavirus genotyping after denaturation of specimens for Hybrid Capture 2 testing: feasibility study for the HPV persistence and progression cohort.
Journal of virological methods 2007;146(1-2):80-5.
2007: Castle Philip E; Rodriguez Ana C; Porras Carolina; Herrero Rolando; Schiffman Mark; Gonzalez Paula; Hildesheim Allan; Burk Robert D
A comparison of cervical and vaginal human papillomavirus.
Sexually transmitted diseases 2007;34(11):849-55.
2007: Pratt M Margaret; Sirajuddin Paul; Poirier Miriam C; Schiffman Mark; Glass Andrew G; Scott David R; Rush Brenda B; Olivero Ofelia A; Castle Philip E
Polycyclic aromatic hydrocarbon-DNA adducts in cervix of women infected with carcinogenic human papillomavirus types: an immunohistochemistry study.
Mutation research 2007;624(1-2):114-23.
2007: Jeronimo Jose; Massad L Stewart; Castle Philip E; Wacholder Sholom; Schiffman Mark;
Interobserver agreement in the evaluation of digitized cervical images.
Obstetrics and gynecology 2007;110(4):833-40.
2007: Castle Philip E; Sideri Mario; Jeronimo Jose; Solomon Diane; Schiffman Mark
Risk assessment to guide the prevention of cervical cancer.
American journal of obstetrics and gynecology 2007;197(4):356.e1-6.
2007: Schiffman Mark; Castle Philip E; Jeronimo Jose; Rodriguez Ana C; Wacholder Sholom
Human papillomavirus and cervical cancer.
Lancet 2007;370(9590):890-907.
2007: Castle Philip E; Dockter Janel; Giachetti Cristina; Garcia Francisco A R; McCormick Mary Kay; Mitchell Amy L; Holladay E Blair; Kolk Daniel P
A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(9):2599-605.
2007: Castle Philip E; Stoler Mark H; Solomon Diane; Schiffman Mark
The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report.
American journal of clinical pathology 2007;127(5):805-15.
2007: Castle Philip E; Sadorra Mark; Garcia Francisco A R; Cullen Allison P; Lorincz Attila T; Mitchell Amy L; Whitby Denise; Chuke Ronald; Kornegay Janet R
Mouthwash as a low-cost and safe specimen transport medium for human papillomavirus DNA testing of cervicovaginal specimens.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(4):840-3.
2007: Saslow Debbie; Castle Philip E; Cox J Thomas; Davey Diane D; Einstein Mark H; Ferris Daron G; Goldie Sue J; Harper Diane M; Kinney Walter; Moscicki Anna-Barbara; Noller Kenneth L; Wheeler Cosette M; Ades Terri; Andrews Kimberly S; Doroshenk Mary K; Kahn Kelly Green; Schmidt Christy; Shafey Omar; Smith Robert A; Partridge Edward E; Garcia Francisco
American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors.
CA: a cancer journal for clinicians 2007;57(1):7-28.
2007: Kreimer Aimée R; Katki Hormuzd A; Schiffman Mark; Wheeler Cosette M; Castle Philip E;
Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(1):11-6.
2007: Seamans Yancy; Loesel Charlie; Jeronimo Jose; Sellors John; Castle Philip E
Effect of cough technique and cryogen gas on temperatures achieved during simulated cryotherapy.
BMC women's health 2007;7():16.
2006: Castle Philip E; Schiffman Mark; Glass Andrew G; Rush Brenda B; Scott David R; Wacholder Sholom; Dunn Anne; Burk Robert D
Human papillomavirus prevalence in women who have and have not undergone hysterectomies.
The Journal of infectious diseases 2006;194(12):1702-5.
2006: Castle Philip E; Sadorra Mark; Garcia Francisco; Holladay E Blair; Kornegay Janet
Pilot study of a commercialized human papillomavirus (HPV) genotyping assay: comparison of HPV risk group to cytology and histology.
Journal of clinical microbiology 2006;44(11):3915-7.
2006: Kovacic Melinda Butsch; Castle Philip E; Herrero Rolando; Schiffman Mark; Sherman Mark E; Wacholder Sholom; Rodriguez Ana C; Hutchinson Martha L; Bratti M Concepción; Hildesheim Allan; Morales Jorge; Alfaro Mario; Burk Robert D
Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality.
Cancer research 2006;66(20):10112-9.
2006: Sherman Mark E; Castle Philip E; Solomon Diane
Cervical cytology of atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H): characteristics and histologic outcomes.
Cancer 2006;108(5):298-305.
2006: Kitchener Henry C; Castle Philip E; Cox J Thomas
Chapter 7: Achievements and limitations of cervical cytology screening.
Vaccine 2006;24 Suppl 3():S3/63-70.
2006: Castle Philip E; Aftab Asma; Saint-Jean Gilbert; Mendez Luis
Detection of carcinogenic human papillomavirus in specimens collected with a novel self-sampling device.
Journal of clinical microbiology 2006;44(6):2158-9.
2006: Kreimer Aimée R; Guido Richard S; Solomon Diane; Schiffman Mark; Wacholder Sholom; Jeronimo José; Wheeler Cosette M; Castle Philip E
Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(5):908-14.
2006: Castle Philip E; Jeronimo Jose; Schiffman Mark; Herrero Rolando; Rodríguez Ana C; Bratti M Concepción; Hildesheim Allan; Wacholder Sholom; Long L Rodney; Neve Leif; Pfeiffer Ruth; Burk Robert D
Age-related changes of the cervix influence human papillomavirus type distribution.
Cancer research 2006;66(2):1218-24.
2005: Castle Philip E; Walker Joan L; Schiffman Mark; Wheeler Cosette M
Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology.
International journal of cancer. Journal international du cancer 2005;117(6):1007-12.
2005: Schiffman Mark; Castle Philip E
The promise of global cervical-cancer prevention.
The New England journal of medicine 2005;353(20):2101-4.
2005: Schiffman Mark; Wheeler Cosette M; Dasgupta Abhijit; Solomon Diane; Castle Philip E;
A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal papanicolaou smears.
American journal of clinical pathology 2005;124(5):722-32.
2005: Castle Philip E; Ashfaq Raheela; Ansari Faryal; Muller Carolyn Y
Immunohistochemical evaluation of heat shock proteins in normal and preinvasive lesions of the cervix.
Cancer letters 2005;229(2):245-52.
2005: Pfeiffer Ruth M; Castle Philip E
With or without a gold standard.
Epidemiology (Cambridge, Mass.) 2005;16(5):595-7.
2005: McGlynn Katherine A; Devesa Susan S; Graubard Barry I; Castle Philip E
Increasing incidence of testicular germ cell tumors among black men in the United States.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5757-61.
2005: Khan Michelle J; Castle Philip E; Lorincz Attila T; Wacholder Sholom; Sherman Mark; Scott David R; Rush Brenda B; Glass Andrew G; Schiffman Mark
The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
Journal of the National Cancer Institute 2005;97(14):1072-9.
2005: Castle Philip E; Solomon Diane; Schiffman Mark; Wheeler Cosette M
Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.
Journal of the National Cancer Institute 2005;97(14):1066-71.
2005: Schiffman Mark; Herrero Rolando; Desalle Rob; Hildesheim Allan; Wacholder Sholom; Rodriguez Ana Cecilia; Bratti Maria C; Sherman Mark E; Morales Jorge; Guillen Diego; Alfaro Mario; Hutchinson Martha; Wright Thomas C; Solomon Diane; Chen Zigui; Schussler John; Castle Philip E; Burk Robert D
The carcinogenicity of human papillomavirus types reflects viral evolution.
Virology 2005;337(1):76-84.
2005: Castle Philip E; Schiffman Mark; Herrero Rolando; Hildesheim Allan; Rodriguez Ana Cecilia; Bratti M Concepcion; Sherman Mark E; Wacholder Sholom; Tarone Robert; Burk Robert D
A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica.
The Journal of infectious diseases 2005;191(11):1808-16.
2005: Herrero Rolando; Castle Philip E; Schiffman Mark; Bratti M Concepción; Hildesheim Allan; Morales Jorge; Alfaro Mario; Sherman Mark E; Wacholder Sholom; Chen Sabrina; Rodriguez Ana C; Burk Robert D
Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica.
The Journal of infectious diseases 2005;191(11):1796-807.
2005: Castle Philip E; Schiffman Mark; Scott David R; Sherman Mark E; Glass Andrew G; Rush Brenda B; Schussler John E; Wacholder Sholom; Lorincz Attila T
Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(5):1311-4.
2005: McIntyre-Seltman Kathleen; Castle Philip E; Guido Richard; Schiffman Mark; Wheeler Cosette M;
Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(5):1165-70.
2005: Pinto Ligia A; Castle Philip E; Roden Richard B; Harro Clayton D; Lowy Douglas R; Schiller John T; Wallace Dora; Williams Marcus; Kopp William; Frazer Ian H; Berzofsky Jay A; Hildesheim Allan
HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood.
Vaccine 2005;23(27):3555-64.
2005: Bergen Andrew W; Qi Ying; Haque Kashif A; Welch Robert A; Garcia-Closas Montserrat; Chanock Stephen J; Vaught Jim; Castle Philip E
Effects of electron-beam irradiation on whole genome amplification.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(4):1016-9.
2005: Castle Philip E; Garcia-Meijide Mariane; Holladay E Blair; Chuke Ronald; Payne Jay; Long Amanda; Siefers Heather; Demuth Franklin; Lorincz Attila T
A novel filtration-based processing method of liquid cytology specimens for human papillomavirus DNA testing by hybrid capture II.
American journal of clinical pathology 2005;123(2):250-5.
2005: Castle Philip E; Schiffman Mark; Herrero Rolando; Hildesheim Allan; Rodriguez Ana-Cecilia; Bratti M Concepcion; Wacholder Sholom; Kendal Hortense; Breheny Anne M; Prior Andrew; Pfeiffer Ruth; Burk Robert D
PCR testing of pooled longitudinally collected cervical specimens of women to increase the efficiency of studying human papillomavirus infection.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(1):256-60.
2004: Castle Philip E; Schiffman Mark; Wheeler Cosette M
Hybrid capture 2 viral load and the 2-year cumulative risk of cervical intraepithelial neoplasia grade 3 or cancer.
American journal of obstetrics and gynecology 2004;191(5):1590-7.
2004: Castle Philip E; Wheeler Cosette M; Solomon Diane; Schiffman Mark; Peyton Cheri L;
Interlaboratory reliability of Hybrid Capture 2.
American journal of clinical pathology 2004;122(2):238-45.
2004: Castle Philip E; Schiffman Mark; Bratti M Concepcion; Hildesheim Allan; Herrero Rolando; Hutchinson Martha L; Rodriguez Ana Cecilia; Wacholder Sholom; Sherman Mark E; Kendall Hortense; Viscidi Raphael P; Jeronimo Jose; Schussler John E; Burk Robert D
A population-based study of vaginal human papillomavirus infection in hysterectomized women.
The Journal of infectious diseases 2004;190(3):458-67.
2004: Castle Philip E
Beyond human papillomavirus: the cervix, exogenous secondary factors, and the development of cervical precancer and cancer.
Journal of lower genital tract disease 2004;8(3):224-30.
2004: Rodríguez Ana Cecilia; Morera Lidia Ana; Bratti Concepción; Herrero Rolando; Cox J Thomas; Morales Jorge; Alfaro Mario; Hutchinson Martha; Castle Philip E; Hildesheim Allan; Schiffman Mark
Performance of direct visual inspection of the cervix with acetic acid and magnification in a previously screened population.
Journal of lower genital tract disease 2004;8(2):132-8.
2004: Pastrana Diana V; Buck Christopher B; Pang Yuk-Ying S; Thompson Cynthia D; Castle Philip E; FitzGerald Peter C; Krüger Kjaer Susanne; Lowy Douglas R; Schiller John T
Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.
Virology 2004;321(2):205-16.
2004: Castle Philip E; Rodriguez Ana-Cecilia; Bowman Frederick P; Herrero Rolando; Schiffman Mark; Bratti M Concepcion; Morera Lidia Ana; Schust Danny; Crowley-Nowick Peggy; Hildesheim Allan
Comparison of ophthalmic sponges for measurements of immune markers from cervical secretions.
Clinical and diagnostic laboratory immunology 2004;11(2):399-405.
2004: Viscidi Raphael P; Schiffman Mark; Hildesheim Allan; Herrero Rolando; Castle Philip E; Bratti Maria C; Rodriguez Ana Cecilia; Sherman Mark E; Wang Sophia; Clayman Barbara; Burk Robert D
Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(2):324-7.
2003: Castle Philip E; Phillips Terry M; Hildesheim Allan; Herrero Rolando; Bratti M Concepcion; Rodríguez Ana Cecilia; Morera Lidia Ana; Pfeiffer Ruth; Hutchinson Martha L; Pinto Ligia A; Schiffman Mark
Immune profiling of plasma and cervical secretions using recycling immunoaffinity chromatography.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(12):1449-56.
2003: Rodríguez A C; Castle P E; Smith J S; Bratti C; Hildesheim A; Schiffman M; Viscidi R; Burk R D; Ashley R L; Castellsagué X; Herrero R
A population based study of herpes simplex virus 2 seroprevalence in rural Costa Rica.
Sexually transmitted infections 2003;79(6):460-5.
2003: Jeronimo J; Castle P E; Herrero R; Burk R D; Schiffman M
HPV testing and visual inspection for cervical cancer screening in resource-poor regions.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2003;83(3):311-3.
2003: Wang S S; Schiffman M; Shields T S; Herrero R; Hildesheim A; Bratti M C; Sherman M E; Rodriguez A C; Castle P E; Morales J; Alfaro M; Wright T; Chen S; Clayman B; Burk R D; Viscidi R P
Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10000 women in Costa Rica.
British journal of cancer 2003;89(7):1248-54.
2003: Heselmeyer-Haddad Kerstin; Janz Viktor; Castle Philip E; Chaudhri Nadia; White Nicole; Wilber Kim; Morrison Larry E; Auer Gert; Burroughs Frances H; Sherman Mark E; Ried Thomas
Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia.
The American journal of pathology 2003;163(4):1405-16.
2003: Castle Philip E; Lorincz Attila T; Scott David R; Sherman Mark E; Glass Andrew G; Rush Brenda B; Wacholder Sholom; Burk Robert D; Manos M Michele; Schussler John E; Macomber Paul; Schiffman Mark
Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer.
Journal of clinical microbiology 2003;41(9):4022-30.
2003: Castle Philip E; Garcia-Closas Montserrat; Franklin Tracie; Chanock Stephen; Puri Vinita; Welch Robert; Rothman Nathaniel; Vaught Jim
Effects of electron-beam irradiation on buccal-cell DNA.
American journal of human genetics 2003;73(3):646-51.
2003: Schiffman Mark; Castle Philip E
Human papillomavirus: epidemiology and public health.
Archives of pathology & laboratory medicine 2003;127(8):930-4.
2003: Pinto Ligia A; Edwards Jessica; Castle Philip E; Harro Clayton D; Lowy Douglas R; Schiller John T; Wallace Dora; Kopp William; Adelsberger Joseph W; Baseler Michael W; Berzofsky Jay A; Hildesheim Allan
Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.
The Journal of infectious diseases 2003;188(2):327-38.
2003: Castle Philip E; Escoffery Carlos; Schachter Julius; Rattray Carole; Schiffman Mark; Moncada Jeanne; Sugai Karlyn; Brown Claudette; Cranston Beverly; Hanchard Barrie; Palefsky Joel M; Burk Robert D; Hutchinson Martha L; Strickler Howard D
Chlamydia trachomatis, herpes simplex virus 2, and human T-cell lymphotrophic virus type 1 are not associated with grade of cervical neoplasia in Jamaican colposcopy patients.
Sexually transmitted diseases 2003;30(7):575-80.
2003: Castle Philip E; Solomon Diane; Hildesheim Allan; Herrero Rolando; Concepcion Bratti M; Sherman Mark E; Cecilia Rodriguez Ana; Alfaro Mario; Hutchinson Martha L; Terence Dunn S; Kuypers Jane; Schiffman Mark
Stability of archived liquid-based cervical cytologic specimens.
Cancer 2003;99(2):89-96.
2003: Sherman Mark E; Lorincz Attila T; Scott David R; Wacholder Sholom; Castle Philip E; Glass Andrew G; Mielzynska-Lohnas Iwona; Rush Brenda B; Schiffman Mark
Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
Journal of the National Cancer Institute 2003;95(1):46-52.
2003: Castle Philip E; Giuliano Anna R
Chapter 4: Genital tract infections, cervical inflammation, and antioxidant nutrients--assessing their roles as human papillomavirus cofactors.
Journal of the National Cancer Institute. Monographs 2003;(31):29-34.
2002: Hildesheim Allan; Ryan Rick L; Rinehart Elizabeth; Nayak Sonali; Wallace Dora; Castle Philip E; Niwa Shelley; Kopp William
Simultaneous measurement of several cytokines using small volumes of biospecimens.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(11):1477-84.
2002: Castle Philip E; Schiffman Mark; Burk Robert D; Wacholder Sholom; Hildesheim Allan; Herrero Rolando; Bratti M Concepcion; Sherman Mark E; Lorincz Attila
Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(11):1394-9.
2002: Castle Philip E; Wacholder Sholom; Sherman Mark E; Lorincz Attila T; Glass Andrew G; Scott David R; Rush Brenda B; Demuth Franklin; Schiffman Mark
Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women.
Cancer 2002;95(10):2145-51.
2002: Castle Philip E; Schiffman Mark; Gravitt Patti E; Kendall Hortense; Fishman Stacy; Dong Huali; Hildesheim Allan; Herrero Rolando; Bratti M Concepcion; Sherman Mark E; Lorincz Attila; Schussler John E; Burk Robert D
Comparisons of HPV DNA detection by MY09/11 PCR methods.
Journal of medical virology 2002;68(3):417-23.
2002: Schiffman Mark; Wheeler Cosette M; Castle Philip E;
Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities.
The Journal of infectious diseases 2002;186(8):1169-72.
2002: Castle Philip E; Wacholder Sholom; Lorincz Attila T; Scott David R; Sherman Mark E; Glass Andrew G; Rush Brenda B; Schussler John E; Schiffman Mark
A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women.
Journal of the National Cancer Institute 2002;94(18):1406-14.
2002: Lorincz Attila T; Castle Philip E; Sherman Mark E; Scott David R; Glass Andrew G; Wacholder Sholom; Rush Brenda B; Gravitt Patti E; Schussler John E; Schiffman Mark
Viral load of human papillomavirus and risk of CIN3 or cervical cancer.
Lancet 2002;360(9328):228-9.
2002: Castle Philip E; Lorincz Attila T; Mielzynska-Lohnas Iwona; Scott David R; Glass Andrew G; Sherman Mark E; Schussler John E; Schiffman Mark
Results of human papillomavirus DNA testing with the hybrid capture 2 assay are reproducible.
Journal of clinical microbiology 2002;40(3):1088-90.
2002: Castle Philip E; Shields Tammy; Kirnbauer Reinhard; Manos M Michele; Burk Robert D; Glass Andrew G; Scott Daivid R; Sherman Mark E; Schiffman Mark
Sexual behavior, human papillomavirus type 16 (HPV 16) infection, and HPV 16 seropositivity.
Sexually transmitted diseases 2002;29(3):182-7.
2002: Castle Philip E; Hildesheim Allan; Bowman Fredrick P; Strickler Howard D; Walker Joan L; Pustilnik Terri; Edwards Robert P; Crowley-Nowick Peggy A
Cervical concentrations of interleukin-10 and interleukin-12 do not correlate with plasma levels.
Journal of clinical immunology 2002;22(1):23-7.
2001: Castle P E; Hillier S L; Rabe L K; Hildesheim A; Herrero R; Bratti M C; Sherman M E; Burk R D; Rodriguez A C; Alfaro M; Hutchinson M L; Morales J; Schiffman M
An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(10):1021-7.
2001: Hildesheim A; Herrero R; Castle P E; Wacholder S; Bratti M C; Sherman M E; Lorincz A T; Burk R D; Morales J; Rodriguez A C; Helgesen K; Alfaro M; Hutchinson M; Balmaceda I; Greenberg M; Schiffman M
HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica.
British journal of cancer 2001;84(9):1219-26.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Philip Castle

Research Profile (preview)

Disorders

Living Beings

Chemicals & Drugs

Procedures

Geographic Areas

Anatomy

Concepts & Ideas

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Philip Castle (preview)

All Publications